Decompose quantitative susceptibility mapping (QSM) to sub-voxel diamagnetic and paramagnetic components based on gradient-echo MRI data

Purpose: A method named DECOMPOSE-QSM is developed to decompose bulk susceptibility measured with QSM into sub-voxel paramagnetic and diamagnetic components based on a three-pool complex signal model. Methods: Multi-echo gradient echo signal is modeled as a summation of three weighted exponentials corresponding to three types of susceptibility sources: reference susceptibility, diamagnetic and paramagnetic susceptibility relative to the reference. Paramagnetic component susceptibility (PCS) and diamagnetic component susceptibility (DCS) maps are constructed to represent the sub-voxel compartments by solving for linear and nonlinear parameters in the model. Results: Numerical forward simulation and phantom validation confirmed the ability of DECOMPOSE-QSM to separate the mixture of paramagnetic and diamagnetic components. The PCS obtained from temperature-variant brainstem imaging follows the Curie’s Law, which further validated the model and the solver. Initial in vivo investigation of human brain images showed the ability to extract sub-voxel PCS and DCS sources that produce visually enhanced contrast between brain structures comparing to threshold QSM.

[1]  Bing Wu,et al.  Magnetic susceptibility anisotropy of human brain in vivo and its molecular underpinnings , 2012, NeuroImage.

[2]  Ferdinand Schweser,et al.  Quantitative Susceptibility Mapping Differentiates between Blood Depositions and Calcifications in Patients with Glioblastoma , 2013, PloS one.

[3]  Ferdinand Schweser,et al.  Quantitative Susceptibility Mapping in Parkinson's Disease , 2016, PloS one.

[4]  Yi Wang,et al.  Quantitative susceptibility mapping (QSM) of white matter multiple sclerosis lesions: Interpreting positive susceptibility and the presence of iron , 2015, Magnetic resonance in medicine.

[5]  G. Ramm,et al.  Role of iron in hepatic fibrosis: one piece in the puzzle. , 2007, World journal of gastroenterology.

[6]  Simon Hametner,et al.  Iron and neurodegeneration in the multiple sclerosis brain , 2013, Annals of neurology.

[7]  Yan Zhang,et al.  Longitudinal change in magnetic susceptibility of new enhanced multiple sclerosis (MS) lesions measured on serial quantitative susceptibility mapping (QSM) , 2016, Journal of magnetic resonance imaging : JMRI.

[8]  Jingjing Xu,et al.  Influence of regional iron on the motor impairments of Parkinson's disease: A quantitative susceptibility mapping study , 2017, Journal of magnetic resonance imaging : JMRI.

[9]  Bing Wu,et al.  High-field (9.4T) MRI of brain dysmyelination by quantitative mapping of magnetic susceptibility , 2011, NeuroImage.

[10]  Eric Westman,et al.  Quantitative susceptibility mapping differentiates between parkinsonian disorders. , 2017, Parkinsonism & related disorders.

[11]  Bing Wu,et al.  Quantitative susceptibility mapping of human brain reflects spatial variation in tissue composition , 2011, NeuroImage.

[12]  R. Bowtell,et al.  Fiber orientation-dependent white matter contrast in gradient echo MRI , 2012, Proceedings of the National Academy of Sciences.

[13]  Kemin Chen,et al.  Region‐specific disturbed iron distribution in early idiopathic Parkinson's disease measured by quantitative susceptibility mapping , 2015, Human brain mapping.

[14]  P. Burger,et al.  MR imaging of compact white matter pathways. , 1988, AJNR. American journal of neuroradiology.

[15]  B. Rutt,et al.  Application of the static dephasing regime theory to superparamagnetic iron‐oxide loaded cells , 2002, Magnetic resonance in medicine.

[16]  E. Haacke,et al.  Theory of NMR signal behavior in magnetically inhomogeneous tissues: The static dephasing regime , 1994, Magnetic resonance in medicine.

[17]  Robert Turner,et al.  Myelin and iron concentration in the human brain: A quantitative study of MRI contrast , 2014, NeuroImage.

[18]  Jong Seung Kim,et al.  Shedding light on tau protein aggregation: the progress in developing highly selective fluorophores. , 2018, Chemical Society reviews.

[19]  C. Hillenbrand,et al.  R2* magnetic resonance imaging of the liver in patients with iron overload. , 2009, Blood.

[20]  Chunlei Liu,et al.  Probing demyelination and remyelination of the cuprizone mouse model using multimodality MRI , 2019, Journal of magnetic resonance imaging : JMRI.

[21]  J. Obeso,et al.  Pathophysiology of the basal ganglia in Parkinson's disease , 2000, Trends in Neurosciences.

[22]  Nicolaas Bloembergen,et al.  Proton Relaxation Times in Paramagnetic Solutions. Effects of Electron Spin Relaxation , 1961 .

[23]  Steffen Bollmann,et al.  Echo time‐dependent quantitative susceptibility mapping contains information on tissue properties , 2017, Magnetic resonance in medicine.

[24]  Siegfried Trattnig,et al.  The influence of brain iron and myelin on magnetic susceptibility and effective transverse relaxation - A biochemical and histological validation study , 2018, NeuroImage.

[25]  Richard Bowtell,et al.  Effects of White Matter Microstructure on Phase and Susceptibility Maps , 2014, Magnetic resonance in medicine.

[26]  Jianrong Xu,et al.  Streaking artifact reduction for quantitative susceptibility mapping of sources with large dynamic range , 2015, NMR in biomedicine.

[27]  F. Bloch,et al.  Line-Narrowing by Macroscopic Motion , 1954 .

[28]  G. Wenning,et al.  Iron in Neurodegeneration – Cause or Consequence? , 2019, Front. Neurosci..

[29]  John F. Schenck,et al.  Imaging of brain iron by magnetic resonance: T2 relaxation at different field strengths , 1995, Journal of the Neurological Sciences.

[30]  Yi Wang,et al.  Morphology enabled dipole inversion (MEDI) from a single‐angle acquisition: Comparison with COSMOS in human brain imaging , 2011, Magnetic resonance in medicine.

[31]  Robert J. S. Brown,et al.  Distribution of Fields from Randomly Placed Dipoles: Free-Precession Signal Decay as Result of Magnetic Grains , 1961 .

[32]  Xue Xiao,et al.  Integrated Laplacian‐based phase unwrapping and background phase removal for quantitative susceptibility mapping , 2014, NMR in biomedicine.

[33]  M. Delong,et al.  Basal Ganglia Circuits as Targets for Neuromodulation in Parkinson Disease. , 2015, JAMA neurology.

[34]  Hongjiang Wei,et al.  Quantitative susceptibility mapping as a biomarker for evaluating white matter alterations in Parkinson’s disease , 2018, Brain Imaging and Behavior.

[35]  J. R. Reichenbach,et al.  SEMI-TWInS : Simultaneous Extraction of Myelin and Iron using a T 2 *-Weighted Imaging Sequence , 2010 .

[36]  David Katz,et al.  The relation between brain iron and NMR relaxation times: An in vitro study , 1996, Magnetic resonance in medicine.

[37]  Christian Langkammer,et al.  Differential developmental trajectories of magnetic susceptibility in human brain gray and white matter over the lifespan , 2014, Human brain mapping.

[38]  S. H. Koenig,et al.  Theory of 1/T1 and 1/T2 NMRD profiles of solutions of magnetic nanoparticles , 1995, Magnetic resonance in medicine.

[39]  N. Gong,et al.  Imaging microstructure with diffusion and susceptibility MR: neuronal density correlation in Disrupted-in-Schizophrenia-1 mutant mice. , 2020, NMR in biomedicine.

[40]  B. Lunghi,et al.  Iron overload enhances the development of experimental liver cirrhosis in mice. , 2003, The international journal of biochemistry & cell biology.

[41]  Nian Wang,et al.  Regionally progressive accumulation of iron in Parkinson's disease as measured by quantitative susceptibility mapping , 2017, NMR in biomedicine.

[42]  Yi Wang,et al.  Quantitative s usceptibility Mapping of Multiple s clerosis lesions at Various ages 1 , 2014 .

[43]  Torsten Rohlfing,et al.  MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping , 2011, NeuroImage.

[44]  Samuel A. Hurley,et al.  Detecting Microglial Density With Quantitative Multi-Compartment Diffusion MRI , 2019, Front. Neurosci..

[45]  Lounila,et al.  Effects of orientational order and particle size on the NMR line positions of lipoproteins. , 1994, Physical review letters.

[46]  M. F. Falangola,et al.  Visualization of β‐amyloid plaques in a transgenic mouse model of Alzheimer's disease using MR microscopy without contrast reagents , 2004, Magnetic resonance in medicine.

[47]  Robert Turner,et al.  Toward in vivo histology: A comparison of quantitative susceptibility mapping (QSM) with magnitude-, phase-, and R2 ⁎-imaging at ultra-high magnetic field strength , 2013, NeuroImage.

[48]  Julio Acosta-Cabronero,et al.  High-resolution characterization of the aging brain using simultaneous quantitative susceptibility mapping ( QSM ) and R 2 * measurements at 7 Tesla , 2016 .

[49]  Hongjiang Wei,et al.  Quantitative Susceptibility Mapping: Contrast Mechanisms and Clinical Applications , 2015, Tomography.

[50]  Bing Wu,et al.  Fast and tissue-optimized mapping of magnetic susceptibility and T2* with multi-echo and multi-shot spirals , 2012, NeuroImage.

[51]  T. Kent,et al.  Revisiting the intersection of amyloid, pathologically modified tau and iron in Alzheimer’s disease from a ferroptosis perspective , 2020, Progress in Neurobiology.

[52]  Siddharama Pawate,et al.  Untangling the R2* contrast in multiple sclerosis: A combined MRI-histology study at 7.0 Tesla , 2018, PloS one.

[53]  David Bonekamp,et al.  Potential of quantitative susceptibility mapping for detection of prostatic calcifications , 2017, Journal of magnetic resonance imaging : JMRI.

[54]  K. Jellinger,et al.  The Role of Iron in Neurodegeneration , 1999, Drugs & aging.

[55]  Christian Langkammer,et al.  Iron mapping using the temperature dependency of the magnetic susceptibility , 2015, Magnetic resonance in medicine.

[56]  J. Slotboom,et al.  Adiabatic slice-selective rf pulses and a single-shot adiabatic localization pulse sequence , 1995 .

[57]  Christian Langkammer,et al.  Effects of formalin fixation and temperature on MR relaxation times in the human brain , 2016, NMR in biomedicine.

[58]  Yi Wang,et al.  Quantitative susceptibility mapping (QSM): Decoding MRI data for a tissue magnetic biomarker , 2014, Magnetic resonance in medicine.

[59]  Y. Rabin,et al.  Thermal Expansion of Blood Vessels and Muscle Specimens Permeated with DMSO, DP6, and VS55 at Cryogenic Temperatures , 2005, Annals of Biomedical Engineering.

[60]  Chunlei Liu,et al.  Imaging the Centromedian Thalamic Nucleus Using Quantitative Susceptibility Mapping , 2020, Frontiers in Human Neuroscience.

[61]  Mark W. Woolrich,et al.  Advances in functional and structural MR image analysis and implementation as FSL , 2004, NeuroImage.

[62]  P. Faller,et al.  Iron(II) binding to amyloid-β, the Alzheimer's peptide. , 2011, Inorganic chemistry.

[63]  G. Allan Johnson,et al.  Quantitative magnetic susceptibility of the developing mouse brain reveals microstructural changes in the white matter , 2014, NeuroImage.

[64]  G. Gamsu,et al.  A preliminary study of MRI quantification of simulated calcified pulmonary nodules. , 1987, Investigative radiology.

[65]  Yimei Zhu,et al.  Fast phase unwrapping algorithm for interferometric applications. , 2003, Optics letters.

[66]  Ferdinand Schweser,et al.  Overview of quantitative susceptibility mapping , 2017, NMR in biomedicine.

[67]  C. Figley,et al.  A Method for Whole Brain Ex Vivo Magnetic Resonance Imaging with Minimal Susceptibility Artifacts , 2016, Front. Neurol..

[68]  Y Wang,et al.  Usefulness of Quantitative Susceptibility Mapping for the Diagnosis of Parkinson Disease , 2015, American Journal of Neuroradiology.

[69]  Wei Li,et al.  Susceptibility tensor imaging (STI) of the brain , 2017, NMR in biomedicine.

[70]  Tracy O'Connor,et al.  Protein aggregation diseases: pathogenicity and therapeutic perspectives , 2010, Nature Reviews Drug Discovery.

[71]  Jeff H. Duyn,et al.  T2*-based fiber orientation mapping , 2011, NeuroImage.

[72]  Yi Wang,et al.  Calculation of susceptibility through multiple orientation sampling (COSMOS): A method for conditioning the inverse problem from measured magnetic field map to susceptibility source image in MRI , 2009, Magnetic resonance in medicine.

[73]  Chunlei Liu,et al.  Whole brain susceptibility mapping using compressed sensing , 2012, Magnetic resonance in medicine.

[74]  Yoshio Hiraki,et al.  Development of a tissue‐equivalent MRI phantom using carrageenan gel , 2003, Magnetic resonance in medicine.

[75]  Chunlei Liu,et al.  Imaging diamagnetic susceptibility of collagen in hepatic fibrosis using susceptibility tensor imaging , 2020, Magnetic resonance in medicine.

[76]  Qing X Yang,et al.  MRI and histological analysis of beta‐amyloid plaques in both human Alzheimer's disease and APP/PS1 transgenic mice , 2009, Journal of magnetic resonance imaging : JMRI.

[77]  David Pitt,et al.  Iron Is a Sensitive Biomarker for Inflammation in Multiple Sclerosis Lesions , 2013, PloS one.

[78]  Chunlei Liu,et al.  Imaging beta amyloid aggregation and iron accumulation in Alzheimer's disease using quantitative susceptibility mapping MRI , 2019, NeuroImage.

[79]  E Mark Haacke,et al.  Quantifying brain iron deposition in patients with Parkinson's disease using quantitative susceptibility mapping, R2 and R2. , 2015, Magnetic resonance imaging.

[80]  Jon-Fredrik Nielsen,et al.  Across‐vendor standardization of semi‐LASER for single‐voxel MRS at 3T , 2019, NMR in biomedicine.

[81]  Arend Heerschap,et al.  Towards 1H-MRSI of the human brain at 7T with slice-selective adiabatic refocusing pulses , 2008, Magnetic Resonance Materials in Physics, Biology and Medicine.

[82]  I. Kuntz,et al.  Thermal expansion of a protein. , 1987, Biochemistry.

[83]  Robert N. Muller,et al.  Theory of proton relaxation induced by superparamagnetic particles , 1999 .

[84]  Nian Wang,et al.  Exploring the origins of echo-time-dependent quantitative susceptibility mapping (QSM) measurements in healthy tissue and cerebral microbleeds , 2017, NeuroImage.

[85]  Se-Hong Oh,et al.  Origin of B 0 orientation dependent R 2 * ( = 1 / T 2 * ) in white matter : magic angle effect vs . magnetic susceptibility , 2012 .

[86]  Stefan Ropele,et al.  The influence of iron oxidation state on quantitative MRI parameters in post mortem human brain , 2020, NeuroImage.

[87]  Daniel C. Alexander,et al.  NODDI: Practical in vivo neurite orientation dispersion and density imaging of the human brain , 2012, NeuroImage.

[88]  M. Jenkinson,et al.  Quantitative Susceptibility Mapping for Characterization of Intraplaque Hemorrhage and Calcification in Carotid Atherosclerotic Disease , 2020, Journal of magnetic resonance imaging : JMRI.